Indokem Ltd vs Tatva Chintan Pharma Chem Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 18, 2026

Key Highlights

The Latest Trading Price of Indokem Ltd is ₹ 510.2 as of 18 Mar 15:30 . The P/E Ratio of Indokem Ltd changed from 165.2 on March 2025 to 0 on March 2022 . This represents a CAGR of -100.00% over 3 yearsThe P/E Ratio of Tatva Chintan Pharma Chem Ltd changed from 81.2 on March 2023 to 53.4 on March 2022 . This represents a CAGR of -8.04% over 5 years The Market Cap of Indokem Ltd changed from ₹ 251.53 crore on March 2023 to ₹ 0 crore on March 2022 . This represents a CAGR of -100.00% over 5 yearsThe Market Cap of Tatva Chintan Pharma Chem Ltd changed from ₹ 3694 crore on March 2023 to ₹ 5115 crore on March 2022 . This represents a CAGR of 6.72% over 5 years The revenue of Indokem Ltd for the Dec '25 is ₹ 44.1 crore as compare to the Sep '25 revenue of ₹ 40.84 crore. This represent the growth of 7.98% The revenue of Tatva Chintan Pharma Chem Ltd for the Dec '25 is ₹ 133.07 crore as compare to the Sep '25 revenue of ₹ 124.52 crore. This represent the growth of 6.87% The ebitda of Indokem Ltd for the Dec '25 is ₹ 2.26 crore as compare to the Sep '25 ebitda of ₹ 1.75 crore. This represent the growth of 29.14% The ebitda of Tatva Chintan Pharma Chem Ltd for the Dec '25 is ₹ 27.22 crore as compare to the Sep '25 ebitda of ₹ 23.22 crore. This represent the growth of 17.23% The net profit of Indokem Ltd changed from ₹ -1.39 crore to ₹ 0.4 crore over 7 quarters. This represents a CAGR of NaN% The net profit of Tatva Chintan Pharma Chem Ltd changed from ₹ 5.21 crore to ₹ 15.17 crore over 7 quarters. This represents a CAGR of 84.17% The Dividend Payout of Indokem Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Tatva Chintan Pharma Chem Ltd changed from 19.56 % on March 2021 to 708.79 % on March 2025 . This represents a CAGR of 105.04% over 5 years .

About Indokem Ltd

Indokem Limited, formerly known as Khatau Junker Limited, a part of Khatau Mahendra Group is promoted by Dharamsey Khatau.
The Company manufactures and deals in dyes, sizing chemicals and auxiliaries used in Textile industry.
It also deals in electrical capacitors.
It has manufacturing and warehouse facility at Dahisar Mori near Mumbai and warehouses at Ahmedabad and Coimbatore locations and manufacturing facilities at Ambernath near Mumbai, Narol-Ahmedabad and Coimbatore locations. A diversified company some times earlier with active presence in Electrical products, Insecticides and Dye stuffs, the company divested its business interest in Electrical products and Insecticides and concentrates on manufacture of Synthetic Organic Dye Stuffs. Incorporated as a private limited company in 1964 in the name of Khatau Junker Limited, it became a deemed public limited company in 1979.

About Tatva Chintan Pharma Chem Ltd

Tatva Chintan Pharma Chem Limited was formerly incorporated as 'Tatva Chintan Pharma Chem Private Limited' on 12 June 1996.
The status of the Company converted from Private Limited into a Public Limited Company from 27 January 2021 and the name of Company changed from 'Tatva Chintan Pharma Chem Private Limited' to 'Tatva Chintan Pharma Chem Limited'.
The Company is promoted by Mr. Chintan Nitin Kumar Shah, Mr. Ajay Kumar Mansukhlal Patel and Mr. Shekhar Rasiklal Somani. The Company is a globally recognized specialty chemical player with several market leading products in its portfolio.
The Company is primarily engaged in manufacturing, distribution and selling of specialty chemicals i.e., Phase Transfer Catalysts (PTC), Structure Directing Agents (SDA), Electrolyte Salts and Solutions (ESS), Pharmaceutical and Agrochemical Intermediates and Other Specialty Chemicals (PASC).

FAQs for the comparison of Indokem Ltd and Tatva Chintan Pharma Chem Ltd

Which company has a larger market capitalization, Indokem Ltd or Tatva Chintan Pharma Chem Ltd?

Market cap of Indokem Ltd is 1,422 Cr while Market cap of Tatva Chintan Pharma Chem Ltd is 2,766 Cr

What are the key factors driving the stock performance of Indokem Ltd and Tatva Chintan Pharma Chem Ltd?

The stock performance of Indokem Ltd and Tatva Chintan Pharma Chem Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Indokem Ltd and Tatva Chintan Pharma Chem Ltd?

As of March 18, 2026, the Indokem Ltd stock price is INR ₹510.2. On the other hand, Tatva Chintan Pharma Chem Ltd stock price is INR ₹1182.85.

How do dividend payouts of Indokem Ltd and Tatva Chintan Pharma Chem Ltd compare?

To compare the dividend payouts of Indokem Ltd and Tatva Chintan Pharma Chem Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.